Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Dr. Chesi studies the biology of multiple myeloma, a tumor of antibody-producing cells in the bone marrow that leads to anemia, renal insufficiency and bone disease. She is interested in identifying the genetic events that lead to myeloma development and progression, in modeling their effects in vivo, and in developing personalized therapeutic strategies that target the cancer cells while boosting the immune system.
Dr. Chesi's highly translational research aims to identify recurrent genetic events and has provided the basis for a myeloma disease risk stratification utilized not only at Mayo Clinic but also around the world. The successful preclinical drug testing performed by Dr. Chesi in a unique clinically predictive model has led to the initiation of several clinical trials using the most promising compounds.
Learn about clinical trials that address specific scientific questions about human health and disease.
Explore all research studies at Mayo Clinic.
See the peer-reviewed findings I have published as a result of my research.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.